Cai Donghan, Guan Guoxian, Liu Xing, Jiang Weizhong, Chen Zhifen
Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fujian 350001, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Jun;19(6):659-63.
To investigate the pattern of lymph node metastasis in patients with left-sided colon cancer in order to provide evidences for the choice of operation mode and the range of lymph node clearance.
Clinical data of 556 cases with left-sided colon carcinoma undergoing surgical treatment in Department of Colorectal Surgery, Fujian Medical University Union Hospital from January 2000 to October 2014 were retrospectively analyzed. Among these patients, cancer of splenic flexure and transverse colon close to splenic flexure (splenic flexure group) was found in 41 cases, descending colon cancer in 73 cases(descending colon goup) and sigmoid colon cancer in 442 cases (sigmoid colon group), respectively; T1 was found in 29 cases, T2 in 63 cases, T3 in 273 cases, T4 in 191 cases. All the patients underwent D3 radical operation or complete mesocolic excision(CME). Para-bowel lymph node was defined as the first station, mesenteric lymph node as the second station, and lymph node in root of mesentery and around upper and inferior mesenteric arteries as the third station. Metastasis was compared among these 3 stations with regard to different sites and tumor invasions.
The total lymph node metastasis rate was 49.6%(276/556). The lymph node metastasis rates of splenic flexure, descending colon and sigmoid colon groups were 53.7%(22/41), 52.1%(38/73) and 48.9%(216/442) respectively without significant difference (P>0.05). The lymph node metastasis rates of the first, second, and third stations were 47.3%(263/556), 16.9%(94/556) and 5.8%(32/556) respectively with significant difference (χ(2)=287.54, P=0.000). In the first, second and third station, the lymph node metastasis rate was 13.8%(4/29), 0 and 0 in T1; 25.4%(16/63), 4.8%(3/63) and 3.2%(2/63) in T2; 45.8%(125/273), 14.7%(40/273) and 4.8%(13/273) in T3; 61.8%(118/191), 26.7%(25/191) and 8.9%(17/191) in T4 respectively. In splenic flexure group, metastasis rates were similar between No.222 and No.232[14.6%(61/41) vs. 12.2%(5/41), χ(2)=0.11, P=1.000] and between No.223 and No.253 [7.3% (3/41) vs. 2.4% (1/41), χ(2)=1.05, P=0.616]. In descending colon group, metastasis rate of No.232 was higher as compared to No.222[15.1%(11/73) vs. 2.7% (2/73), χ(2)=6.84, P=0.017]; metastasis rate of No.253 was slightly higher as compared to No.223 without significant difference [4.1%(3/73) vs. 0, χ(2)=3.06, P=0.245]. Metastasis rates of No.222 and No.223 in splenic flexure group were significantly higher than those in descending colon and sigmoid colon groups (χ(2)=5.69, P=0.025; Fisher exact test, P=0.044); While such rates of No.232(No.242 for sigmoid colon group) and No.253 were not significantly different among 3 groups respectively (χ(2)=0.90, P=0.660; χ(2)=1.14, P=0.611).
Left-sided colon cancers in T1 should undergo D2 radical operation, while cancers in T2 to T4 should undergo D3 radical operation. The D3 radical operation for splenic flexure cancers and cancers of transverse colon close to splenic flexure should clear No.223 and No.253. The D3 radical operation for descending colon cancer should clear No.222 and No.253. The D3 radical operation for sigmoid colon should clear No.253.
探讨左半结肠癌患者的淋巴结转移规律,为手术方式的选择及淋巴结清扫范围提供依据。
回顾性分析2000年1月至2014年10月在福建医科大学附属协和医院结直肠外科接受手术治疗的556例左半结肠癌患者的临床资料。其中脾曲及靠近脾曲的横结肠癌(脾曲组)41例,降结肠癌73例(降结肠组),乙状结肠癌442例(乙状结肠组);T1期29例,T2期63例,T3期273例,T4期191例。所有患者均行D3根治术或完整结肠系膜切除术(CME)。肠旁淋巴结为第一站,肠系膜淋巴结为第二站,肠系膜根部及肠系膜上、下动脉周围淋巴结为第三站。比较不同部位及肿瘤侵犯情况下这3站的转移情况。
总淋巴结转移率为49.6%(276/556)。脾曲组、降结肠组和乙状结肠组的淋巴结转移率分别为53.7%(22/41)、52.1%(38/73)和
48.9%(216/442),差异无统计学意义(P>0.05)。第一、二、三站的淋巴结转移率分别为47.3%(263/556)、16.9%(94/556)和5.8%(32/556),差异有统计学意义(χ(2)=287.54,P=0.000)。在第一、二、三站中,T1期的淋巴结转移率分别为13.8%(4/29)、0和0;T2期为25.4%(16/63)、4.8%(3/63)和3.2%(2/63);T3期为45.8%(125/273)、14.7%(40/273)和4.8%(13/273);T4期为61.8%(118/191)、26.7%(25/191)和8.9%(17/191)。在脾曲组中,第222组和第232组之间的转移率相似[14.6%(6/41)对12.2%(5/41),χ(2)=0.11,P=1.000],第
223组和第253组之间也相似[7.3%(3/41)对2.4%(1/41),χ(2)=1.05,P=0.616]。在降结肠组中,第232组的转移率高于第222组[15.1%(11/73)对2.7%(2/73),χ(2)=6.84,P=0.017];第253组的转移率略高于第223组,但差异无统计学意义[4.1%(3/73)对0,χ(2)=3.06,P=0.245]。脾曲组中第222组和第223组的转移率显著高于降结肠组和乙状结肠组(χ(2)=5.69,P=0.025;Fisher确切概率法,P=0.044);而第232组(乙状结肠组为第242组)和第253组的转移率在3组之间差异无统计学意义(χ(2)=0.90,P=0.660;χ(2)=1.14,P=0.611)。
T1期左半结肠癌应行D2根治术,T2至T4期癌应行D3根治术。脾曲癌及靠近脾曲的横结肠癌的D3根治术应清扫第223组和第253组。降结肠癌的D3根治术应清扫第222组和第253组。乙状结肠癌的D3根治术应清扫第253组。